Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
Phase 2
Not yet recruiting
- Conditions
- Cognitive DeclineAlzheimer DiseaseMild Cognitive Impairment
- Interventions
- Drug: Resveratrol, Quercetin, and Curcumin (RQC)
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Zaparackas and Knepper LTD
- Target Recruit Count
- 200
- Registration Number
- NCT06470061
- Locations
- 🇺🇸
Zaparackas & Knepper Ltd., Chicago, Illinois, United States
News
No news found